<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04222166</url>
  </required_header>
  <id_info>
    <org_study_id>19-003</org_study_id>
    <nct_id>NCT04222166</nct_id>
  </id_info>
  <brief_title>Registry of Amniotic Membrane: Evaluating Utilization and Outcomes in Various Applications</brief_title>
  <official_title>Registry of Amniotic Membrane: Evaluating Utilization and Outcomes in Various Applications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MED Institute Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MED Institute Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry will assess clinical outcomes following the use of Cryopreserved Amniotic
      Membrane (CAM) for the treatment of orthopedic and various other conditions. This registry
      will collect outcomes data via a registry of up to 100 patients who have received treatment
      with CAM in the post-market setting. Patients will be enrolled from up to five healthcare
      centers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this registry is to collect outcomes data via a registry on the uses of CAM
      in the post-market setting, including:

        -  Adverse events related to the treatment, or the product, will be collected for up to 12
           weeks following the treatment.

        -  Improvements in appropriate effectiveness markers for CAM use in patients treated for
           various conditions.

        -  Improvements in overall quality of life resulting from CAM treatment in patients.

      An additional objective is to determine standard of care follow-up for the target treatments,
      including effectiveness metrics used and typical follow-up schedule.

      This registry is intended to collect clinical data from patients for analysis purposes only
      and will not be used to treat patients. The plan does not allow for any deviation from
      standard of care practice. Therefore, there is no added risk to patients from participating
      in the registry.

      The sponsor will use an electronic data capture (EDC) system for capturing all the data from
      the sites. The system will be built and validated prior to initiation of the sites. Each
      participating physician or appropriately trained designee shall enter data into the EDC
      system, providing all applicable data and documentation to the sponsor. Data will be reviewed
      for missing data, data consistency, and reasonableness of responses. Discrepancies will be
      resolved through a formal query process within the EDC system, and may involve direct contact
      with hospital staff.

      The conduct of the registry will be supervised through a process of centralized and on-site
      monitoring. The sponsor may remotely monitor the registry for data completeness and for
      adverse events. On-site monitoring will be implemented as necessary throughout the course of
      the registry. The physician/clinic will provide direct access to source data/documents for
      registry-related monitoring, audits and IRB review.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>12 Weeks</target_duration>
  <primary_outcome>
    <measure>Incidence of related serious adverse events</measure>
    <time_frame>12 weeks</time_frame>
    <description>Number of related serious adverse events occurred</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in pain score (0-10; higher scores mean worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in analgesic use</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in analgesic use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in wound size</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in wound size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to complete wound closure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Time to complete wound closure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Orthopedic Disorder</condition>
  <condition>Wound</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>CAM</intervention_name>
    <description>Cryopreserved Amniotic Membrane</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A patient is suitable for inclusion in this registry if the patient has been treated with
        CAM for any indication as per the standard of care practice.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • A patient is suitable for inclusion in this registry if the patient has been treated with
        CAM for any indication as per the standard of care practice.

        Exclusion Criteria:

        • Patients are excluded from registry enrollment if they are under the age of 22 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore Heise, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>MED Institute Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pratik Kalsaria, MS</last_name>
    <phone>765-463-1633</phone>
    <email>pkalsaria@medinstitute.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Regenerative Medicine and Pain Management Physicians</name>
      <address>
        <city>Gulf Breeze</city>
        <state>Florida</state>
        <zip>32563</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Bane</last_name>
    </contact>
    <investigator>
      <last_name>Ruben Timmons, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foot and Ankle Specialists of South Jersey</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Crawford</last_name>
    </contact>
    <investigator>
      <last_name>Frank Tursi, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 3, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2020</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

